Olanzapine OD Tablets 5 mg
Phase 1Completed 0 watching 0 views this week๐ค Quiet
30
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedAbout Olanzapine OD Tablets 5 mg
Olanzapine OD Tablets 5 mg is a phase 1 stage product being developed by Dr. Reddy's Laboratories for Fed. The current trial status is completed. This product is registered under clinical trial identifier NCT01503450. Target conditions include Fed.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01503450 | Phase 1 | Completed |
| NCT01503437 | Phase 1 | Completed |
Competing Products
20 competing products in Fed